Pharma News, 2018

Roche’s Hemlibra officially has the hemophilia indication it’s been waiting for—and that its competitors have been dreading.

Gilead Sciences has one-upped Novartis in England's CAR-T market.

Bayer’s recently approved weekly hemophilia treatment Jivi gives patients far more flexibility than those that need to be taken every day or so.

PepsiCo on Tuesday joined the growing list of big companies to confirm potential interest in making drinks with cannabis.

One in two women and one in three men will likely be diagnosed with dementia, Parkinson's disease, or stroke in their lifetime, estimate Dutch researchers in an observational study published onlin...

Roche has unveiled late-stage data showing that its experimental antivrial drug baloxavir marboxil hit efficacy and safety targets in patients with flu.

India’s Dr.

It probably won't surprise you to learn that pain is one of the most common reasons adults seek medical care.

U.

Three scientists shared this year’s Nobel Prize in Chemistry for tapping the power of evolutionary biology to design molecules with a range of practical uses.

Sanofi and Regeneron’s imunotherapy Libtayo has been cleared in the US to treat patients with certain forms of cutaneous squamous cell carcinoma (CSCC).

China has announced a 14% jump in the number of its citizens who are living with HIV and Aids.